Pasteau V - Search Results

1

Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine.

Cussac D, Pasteau V, Millan MJ. Cussac D, et al. Among authors: pasteau v. Eur J Pharmacol. 2004 Feb 6;485(1-3):111-7. doi: 10.1016/j.ejphar.2003.11.077. Eur J Pharmacol. 2004. PMID: 14757130

2

Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.

Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ. Cussac D, et al. Among authors: pasteau v. Mol Pharmacol. 2002 Sep;62(3):578-89. doi: 10.1124/mol.62.3.578. Mol Pharmacol. 2002. PMID: 12181434

3

Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes.

Mannoury la Cour C, Herbelles C, Pasteau V, de Nanteuil G, Millan MJ. Mannoury la Cour C, et al. Among authors: pasteau v. J Neurochem. 2008 Apr;105(2):308-23. doi: 10.1111/j.1471-4159.2007.05131.x. Epub 2007 Nov 16. J Neurochem. 2008. PMID: 18021295 Free article.

4

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.

Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, Lavielle G. Millan MJ, et al. Among authors: pasteau v. J Pharmacol Exp Ther. 2008 Feb;324(2):587-99. doi: 10.1124/jpet.107.126706. Epub 2007 Nov 16. J Pharmacol Exp Ther. 2008. PMID: 18024789

5

Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.

Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ. Mannoury la Cour C, et al. Among authors: pasteau v. Mol Pharmacol. 2011 Jan;79(1):91-105. doi: 10.1124/mol.110.065409. Epub 2010 Oct 15. Mol Pharmacol. 2011. PMID: 20952497

6

G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.

Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ. Newman-Tancredi A, et al. Among authors: pasteau v. Mol Pharmacol. 1999 Mar;55(3):564-74. Mol Pharmacol. 1999. PMID: 10051542

7

Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism.

Cussac D, Newman-Tancredi A, Pasteau V, Millan MJ. Cussac D, et al. Among authors: pasteau v. Mol Pharmacol. 1999 Nov;56(5):1025-30. doi: 10.1124/mol.56.5.1025. Mol Pharmacol. 1999. PMID: 10531409

8

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.

Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ. Newman-Tancredi A, et al. Among authors: pasteau v. Brain Res. 2001 Nov 30;920(1-2):41-54. doi: 10.1016/s0006-8993(01)02927-4. Brain Res. 2001. PMID: 11716810

9

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.

Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D. Millan MJ, et al. Among authors: pasteau v. J Pharmacol Exp Ther. 2003 Sep;306(3):954-64. doi: 10.1124/jpet.103.051797. Epub 2003 May 15. J Pharmacol Exp Ther. 2003. PMID: 12750432

10

Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.

Mannoury la Cour C, Vidal S, Pasteau V, Cussac D, Millan MJ. Mannoury la Cour C, et al. Among authors: pasteau v. Neuropharmacology. 2007 Mar;52(3):1003-14. doi: 10.1016/j.neuropharm.2006.10.021. Epub 2006 Dec 18. Neuropharmacology. 2007. PMID: 17178132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page